Clinical Trial Update: MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma Patients [Phase 2, Phase 3]

View source ↗

Summary

This document provides an update on a Phase 2/Phase 3 clinical trial evaluating the efficacy and safety of propranolol 80 mg in patients with melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Azienda Sanitaria di Firenze | Conditions: Melanoma | Phase 2, Phase 3 | Status: UNKNOWN